Jennifer King

Jennifer King currently serves as the Senior Director of Clinical Pharmacology, DMPK, and Toxicology at Tisento Therapeutics, a position held since August 2023. Prior to this role, Jennifer held similar senior director positions at Cyclerion and Urovant Sciences, building extensive expertise in clinical pharmacology and development. With a foundation that includes significant roles at Roivant Sciences and AbbVie, Jennifer has a comprehensive background spanning over two decades in the pharmaceutical and clinical research fields. Jennifer's academic credentials include a Pharm.D. from the University of North Carolina at Chapel Hill, complemented by a post-doctoral fellowship in antiviral and antiretroviral pharmacology.